AstronauTx is developing targeted therapeutics to restore the functionality of astrocytes, which are critical for maintaining brain health. This approach aims to correct disrupted brain physiology associated with neurodegenerative diseases, potentially improving patient outcomes.
Funding
$68.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NVFounders
Product
Problem
Neurodegenerative diseases are associated with disrupted brain physiology, particularly affecting astrocytes, which are crucial for maintaining brain health and neuronal function. Current treatments often focus on neurons, neglecting the critical role of astrocytes in disease progression and overall brain health. This gap in therapeutic approaches limits the potential for comprehensive treatment and improved patient outcomes.
Solution
AstronauTx is developing targeted therapeutics designed to restore the functionality of astrocytes, addressing the disrupted brain physiology associated with neurodegenerative diseases. By focusing on astrocytes, their approach aims to correct imbalances in the brain's microenvironment, supporting neuronal health and slowing disease progression. Their therapeutics target specific astrocyte functions that are compromised in neurodegenerative conditions, potentially leading to more effective and comprehensive treatments. This approach seeks to improve overall brain health by restoring the supportive and regulatory roles of astrocytes.
Target Audience
The primary target audience includes individuals affected by neurodegenerative diseases, as well as researchers and clinicians focused on developing new treatments for these conditions.
Features
- Targeted therapeutics to modulate astrocyte function
- Focus on restoring disrupted brain physiology
- Aims to improve neuronal health by targeting astrocytes
- Development of treatments for neurodegenerative diseases